The tale of ‘the terrible twosome’ #kickingmyelomasbutt
Kellie and Rita have walked the same path since their diagnoses, but they've had very different experiences.
- Myeloma
Tag: Myeloma
Novel combination therapy now available for myeloma patients through PBS
The Leukaemia Foundation has welcomed news that a new novel combination therapy option will now be available to more myeloma patients through the Pharmaceutical Benefits Scheme (PBS).
- Advocacy and policy
- Media releases
- Myeloma
Friendship an “absolute blessing” after bereavement
Not only do Lynette (Lyn) Healy and Lynnette (Lynnie) Coupar share the same name, but also the tragedy of losing a partner to blood cancer.
- Grief and loss
- Myeloma
Addressing knowledge gaps in immunoglobulin therapy
Dr Khai Li Chai is working to improve the prevention and treatment of infection in blood cancer patients with antibody replacement therapy.
- Chronic lymphocytic leukaemia
- Myeloma
- Non-Hodgkin lymphoma
- Research
- Treatments and side-effects
Blood cancer doesn’t stop: Paul’s story
Super survivor Paul is thought to be one of the first Australians with myeloma to conquer COVID-19.
- Myeloma
Leukaemia Foundation prepares for spike in myeloma cases ahead of COVID-19 restrictions lifting
- Media releases
- Myeloma
Treatment for more Australians living with myeloma now available through Pharmaceutical Benefits Scheme (PBS)
- Advocacy and policy
- Media releases
- Myeloma
Leukaemia Foundation invests $2.6m+ in innovative myeloma research
Better understanding and treating myeloma is the focus of eight research projects that are part of the Leukaemia Foundation’s National Research Program.
- Acute lymphoblastic leukaemia
- Acute myeloid leukaemia
- Myeloma
- Research
PBAC reconsidered plitidepsin for myeloma
The Pharmaceutical Benefits Advisory Committee (PBAC) considered four blood cancer treatments at its March 2020 meeting including a drug for myeloma – plitidepsin (Aplidin®).
- Advocacy and policy
- Myeloma
- Treatments and side-effects
Leukaemia Foundation helps fund more priority driven research
- Media releases
- Myeloma
- Research